The Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric Bypass
Completed · Early Phase 1 · Has a placebo group
Conditions studied: Type 2 Diabetes Mellitus
In brief
The study is being undertaken to understand how the Roux-en-Y Gastric Bypass procedure can affect insulin secretion after meals. The hypothesis of this study is the Disposition Index is decreased in subjects who had previously undergone Roux-en-Y Gastric Bypass by glucagon-like peptide-1 (GLP-1) receptor blockade.
Key facts
- Study ID
- NCT01843881
- Run by
- Adrian Vella
- People needed
- 20
- Starts
- 2012-03-01
- Expected to finish
- 2013-12-01
- Last updated by the study team
- 2013-12-04
Who can join
Age: 20 and older, up to 70. Sex: any. Healthy volunteers: accepted.
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.